Movicol

Macrogol 3350, the active ingredient in Movicol, is an osmotic laxative presented as an oral solution (powder for solution) for oral use. It treats constipation, faecal impaction and is used for bowel preparation in diagnostic procedures.

GNH USA supplies Movicol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Movicol, an osmotic laxative, is indicated for conditions that benefit from increased intestinal water content and stool softening.

- Constipation: provides softening of stool and facilitates regular bowel movements. - Faecal impaction: helps to break down hardened stool and promote evacuation. - Bowel preparation for diagnostic procedures: clears the intestinal tract to improve visualization during colonoscopy or imaging.

Movicol may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating: feeling of fullness or swelling in the abdomen. - Nausea: mild to moderate sensation of wanting to vomit. - Diarrhoea: loose, watery stools occurring after dose. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Electrolyte imbalance: abnormal levels of sodium or potassium that may require medical attention. - Severe abdominal pain: intense pain that could indicate complications. - Allergic reaction: rash, itching, swelling, or difficulty breathing.

Before prescribing Movicol, consider the following precautions to ensure safe use.

- Renal impairment: assess kidney function as reduced clearance may affect electrolyte balance. - Heart failure: monitor fluid status because osmotic agents can increase intravascular volume. - Electrolyte disorders: check baseline sodium and potassium levels prior to treatment. - Dehydration: ensure adequate fluid intake to prevent worsening dehydration. - Use in the elderly: start with lower dose and monitor for adverse effects. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture.

Movicol can interact with certain medicines, altering their effectiveness or safety.

Major Interactions (Avoid): - Lithium: concurrent use may increase lithium levels and risk of toxicity. - Digoxin: osmotic shifts can affect serum potassium, potentially enhancing digoxin toxicity. - Antacids containing magnesium or aluminum: may reduce the laxative effect of Movicol.

Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate electrolyte disturbances; monitor serum electrolytes. - ACE inhibitors or ARBs: watch for additive effects on potassium levels. - NSAIDs: increased risk of renal impairment when combined with osmotic laxatives.